ACET
Price
$1.11
Change
-$0.07 (-5.93%)
Updated
Nov 28, 6:59 PM EST
105 days until earnings call
HARP
Price
$10.54
Change
+$0.80 (+8.21%)
Updated
Nov 28, 6:59 PM EST
Ad is loading...

Compare trend and price ACET vs HARP

Header iconACET vs HARP Comparison
Open Charts ACET vs HARPBanner chart's image
Adicet Bio
Price$1.11
Change-$0.07 (-5.93%)
Volume$169K
CapitalizationN/A
Harpoon Therapeutics
Price$10.54
Change+$0.80 (+8.21%)
Volume$47.6K
CapitalizationN/A
View a ticker or compare two or three
ACET vs HARP Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ACET vs. HARP commentary
Nov 29, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and HARP is a Buy.

COMPARISON
Comparison
Nov 29, 2023
Stock price -- (ACET: $1.11 vs. HARP: $10.54)
Brand notoriety: ACET and HARP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACET: 70% vs. HARP: 76%
Market capitalization -- ACET: $50.93M vs. HARP: $164.92M
ACET [@Biotechnology] is valued at $50.93M. HARP’s [@Biotechnology] market capitalization is $164.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileHARP’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • HARP’s FA Score: 0 green, 5 red.
According to our system of comparison, ACET is a better buy in the long-term than HARP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 2 TA indicator(s) are bullish while HARP’s TA Score has 5 bullish TA indicator(s).

  • ACET’s TA Score: 2 bullish, 5 bearish.
  • HARP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, HARP is a better buy in the short-term than ACET.

Price Growth

ACET (@Biotechnology) experienced а -3.48% price change this week, while HARP (@Biotechnology) price change was -18.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.68%. For the same industry, the average monthly price growth was +33.10%, and the average quarterly price growth was +8.38%.

Reported Earning Dates

ACET is expected to report earnings on Mar 13, 2024.

HARP is expected to report earnings on Nov 08, 2023.

Industries' Descriptions

@Biotechnology (+1.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ACET with price predictions.
OPEN
A.I.dvisor published
a Summary for HARP with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
HARP($165M) has a higher market cap than ACET($50.9M). HARP YTD gains are higher at: 45.239 vs. ACET (-87.584). HARP has higher annual earnings (EBITDA): -25.4M vs. ACET (-137.52M). ACET has more cash in the bank: 183M vs. HARP (31.6M). HARP has less debt than ACET: HARP (14.5M) vs ACET (21.8M). HARP has higher revenues than ACET: HARP (37.3M) vs ACET (0).
ACETHARPACET / HARP
Capitalization50.9M165M31%
EBITDA-137.52M-25.4M541%
Gain YTD-87.58445.239-194%
P/E Ratio6.06N/A-
Revenue037.3M-
Total Cash183M31.6M579%
Total Debt21.8M14.5M150%
FUNDAMENTALS RATINGS
ACET: Fundamental Ratings
ACET
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
23
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACETHARP
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 27 days ago
83%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JBAVX25.150.04
+0.16%
JHancock Balanced R5
TCBAX8.800.01
+0.11%
Covered Bridge A
WCPSX96.84N/A
N/A
Communication Services UltraSectorProSvc
IJSAX11.68-0.07
-0.60%
VY® JPMorgan Small Cap Core Equity A
LVOPX15.68-0.13
-0.82%
Lord Abbett Value Opportunities P

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with OGI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
-5.93%
OGI - ACET
41%
Loosely correlated
+1.60%
CYTK - ACET
40%
Loosely correlated
-1.92%
DVAX - ACET
39%
Loosely correlated
-2.57%
DCPH - ACET
39%
Loosely correlated
+0.66%
NKTX - ACET
39%
Loosely correlated
-2.77%
More

HARP and

Correlation & Price change

A.I.dvisor indicates that over the last year, HARP has been loosely correlated with MDGL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if HARP jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HARP
1D Price
Change %
HARP100%
+8.21%
MDGL - HARP
39%
Loosely correlated
-3.22%
ACET - HARP
39%
Loosely correlated
-5.93%
ORMP - HARP
39%
Loosely correlated
-1.36%
CYTK - HARP
34%
Loosely correlated
-1.92%
VNDA - HARP
34%
Loosely correlated
-0.28%
More